Clinical Drug Experience Knowledgebase

Adenoviridae Infections (Phase 2)

Anemia (Phase 2)

Anemia, Aplastic (Phase 2)

Anemia, Diamond-Blackfan (Phase 3)

Anemia, Sickle Cell (Phase 3)

Burkitt Lymphoma (Phase 3)

Communicable Diseases (Phase 3)

Epstein-Barr Virus Infections (Phase 2)

Graft vs Host Disease (Phase 3)

Granulomatous Disease, Chronic (Phase 2)

Hemoglobinopathies (Phase 3)

Immunologic Deficiency Syndromes (Phase 2)

Infections (Phase 3)

Leukemia (Phase 3)

Leukemia, Biphenotypic, Acute (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 3)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Lymphohistiocytosis, Hemophagocytic (Phase 2)

Lymphoma (Phase 3)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Follicular (Phase 3)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Mantle-Cell (Phase 3)

Lymphoma, Non-Hodgkin (Phase 3)

Multiple Myeloma (Phase 3)

Mycoses (Phase 3)

Myelodysplastic-Myeloproliferative Diseases (Phase 3)

Myelodysplastic Syndromes (Phase 3)

Myeloproliferative Disorders (Phase 3)

Neoplasm, Residual (Phase 2)

Neoplasms, Plasma Cell (Phase 3)

Neutropenia (Phase 3)

Pneumonia (Phase 3)

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 3)

Preleukemia (Phase 3)

Syndrome (Phase 3)

Thalassemia (Phase 3)

Tissue Adhesions (Phase 2)

Virus Diseases (Phase 2)